Member Info for Tillywhiz

News rich period for sure

Septembers/ October RNS - absorb & wonder what next RNS might be 🤔…

6th Oct 2025 7:00 am RNS Clearance to Initiate Pediatric Enrolment

P3 update , CDX , CBR updates perhaps

30th Sep 2025 7:00 am RNS Half-year Report

23rd Sep 2025 7:00 am RNS Hemogenyx Signs Letter of Intent

18th Sep 2025 1:16 pm RNS Holding(s) in Company

17th Sep 2025 7:00 am RNS Third Patient Safety. ( stand out RNS imo )

11th Sep 2025 7:00 am RNS-R Invitation to Participate at DCNY Summit

8th Sep 2025 7:00 am RNS Manufacturing Partnership with Made Scientific

Volatility gives investment opportunities at current levels imo

Short term good , medium term superb , long term Biblical 👍🍷

You still here ,

Fetch the Hemo Grog for actual investors

Science gaining traction

Toffee & all

Your unhinged & a known shorter ( previous moniker matrix , Kira & many others )

I have a huge holding as been invested 10 yr at a very low average

So Lovely Jubbly 👏👍

Science gaining traction

Wild start - back in auction 3 times

Current 1190-1290

Toffee & all

No one gives a crap , now run along and put the kettle on

Auction to start at 12.00

Beautiful 👍👏

Toxic traders will crawl out from the swamp & waffle negativity,

However it ain’t gunna do diddly squat to changing the progression of Hemo science & subsequent stock re rate for all invested

Lovely Jubbly 👏👏

In the words of Del Boy

Lovely Jubbly 👏

Well said Micky 👍💪

Great line from rns 👏

underpins our pipeline and supports long-term growth."

Another absolute whacker highlighting Hemos successful science 👏 👏👏

Fetch the Hemo Grog 👍🍷

As noted news rich period expected & another quality rns for all invested 👍👍🍷

This expansion not only increases the potential reach and impact of HG-CT-1 but also underscores the value of the Company's strong intellectual property portfolio, which underpins our pipeline and supports long-term growth."

Morning all invested

Hemo science cogs keep turning & news in multiple fronts expected ,

Let’s see what this week brings .

Stand out quote from recent RNS whilst eating your weetabix , , pharmas will be watching eagerly.

‘quote RNS ‘ Preliminary assessment shows that original AML cells were not detectable in the patient using standard testing methods. ‘.

Short term good , medium term superb , long term Biblical 👍🍷

The irony of your post ,

You pop up blaming all for your accusative posts removed when the likely reason is LSE removed them as you were posting shorting live links on short tracker which is against LSE rules , & yet now pointing the finger of removal at myself regarding posting info from Ortex which you asked for Friday . Unhinged .

I post the info via interpretation not live Links hence allowed & do it for the benefit of fellow investors especially lth’s without agenda & have done for yrs , & certainly don’t remember you been invested here in yrs gone by , even on your previous 5 banned monikers .

FFS give it a rest , Your making issues that aren’t there arguing over the colour of orange juice , like i said stay off the evening grog & wind your neck in .

Onwards & upwards with Hemo

Fair enough HFH , then help yourself to the top shelf beverages 👍

Science data ultimately is the sails & rudder of the Hemo ship however the market data can tell you which way the wind is blowing short term .

Enjoy your Sunday Dude .

Hfh & all

Sorry mate t but that’s rather a condescending line ,

LTH s like myself have been here longer than most & I am here for the science hence putting my investment in many times ,

Putting factual Market data to put right the spurious dung spreaders is important for many whilst awaiting the science updates as it gives guidance to further investment opportunities.

We all list the science data & rns but also shouldn’t ignore the ships rudder or market shenanigans.

All the best to all LTHs

Must more important than shorts or market shenanigans is Hemo Science 👍

Hemo on Ortex today .

Hemogenyx Pharmaceuticals (HEMO) has shown remarkable movement in the biotech sector, rising 38.31% above its peers over the past month.

This surge is coupled with a significant uptick in news and social media mentions in the last 24 hours, highlighting increased attention towards the company.

Hemogenyx, with a market cap of $77,838,443, stands out in the biotech landscape amidst this heightened activity.

Septembers RNS - absorb & wonder what next RNS might be 🤔…

P3 update , CDX , CBR updates perhaps

30th Sep 2025 7:00 am RNS Half-year Report

23rd Sep 2025 7:00 am RNS Hemogenyx Signs Letter of Intent

18th Sep 2025 1:16 pm RNS Holding(s) in Company

17th Sep 2025 7:00 am RNS Third Patient Safety. ( stand out RNS imo )

11th Sep 2025 7:00 am RNS-R Invitation to Participate at DCNY Summit

8th Sep 2025 7:00 am RNS Manufacturing Partnership with Made Scientific

Quiet periods or pullbacks give investment opportunities at current levels imo

Fetch the Hemo Sunday Grog

Without & all

Yes , as hedges against larger longs for risk balance perhaps .

However not that Flagged short that closed last week 28,000 by Hamilton Stuart capital they opened on the 15th a known shorting group , probably trying to fleece the rise in Hemo 👎

They have been in bother with FCA previously & fined for dodgy shenanigans.

Good riddance to that sack of toxic dung .

Updated shorts / stock on loan

Current - 20,300

( 3000 closed on Friday ) - ( could be remaining Hamilton loan left from flagged closing - difficult as under the 0.5% threshold)

Wednesday- 23,300

Monday - 21,200

Free float % on loan -0.47

Value on loan - 226,000

No of loans 8

Cost to borrow - 26%

Wednesday- 30%

Days to cover - 0.16

No flagged shorts outstanding

Existing flagged short 0.1 %

Short score - 37

There is limited & low shorting interest in Hemo as % of freefloat low & high cost to borrow + low freefloat of stock available so risky for brokers to cover .

Imo the shenanigans other week we’re all fully orchestrated- substantial rise on Hemo science & - large flagged shorts opened taking advantage & close out - leaving the stock in this 10.50 - 13.50 trading band in low volume until next RNS drops

& all the shenanigans north & the toxic posters will be back as seem to have all disappeared.

Hemo science will prevail as it has & if the science does what it says on the tin all shorts & traders will be crushed in the rise . 👍🍷

Updated3 Oct 2025 16:30

Toffers & all

Stay off the night Grog , Your unhinged, get over yourself I don’t give two craps about your posts & don’t report or bin anyone ,

Just call out anyone nibbling my ass or talking toxic crap .

You spring up all guns blazing talking out of your backside

I post Ortex detail regularly for all to read it is accurate & shows all flagged & smaller shorts including when the loans were taking out & by how much , you have to pay for Ortex it’s. Premium info

Will post the updated detailed accurate shorts shortly .

Don’t let the clock erase the last clinical RNS , hence why the stock covered 1000%

P3 stand out RNS statement -

‘quote RNS ‘ Preliminary assessment shows that original AML cells were not detectable in the patient using standard testing methods. ‘. 👍

Just pause & what do you think the next imminent RNS will be in association to this statement , pharmas will certainly be watching & the world of science.

Mouthwatering if says what it does on the tin , who knows what offers will land on the table . 👍🍷

Pullbacks are buying opportunities imo .